{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T13:28:19Z","timestamp":1783603699891,"version":"3.55.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100002197","name":"Maine Cancer Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002197","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Immunological Methods"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.jim.2019.112671","type":"journal-article","created":{"date-parts":[[2019,9,15]],"date-time":"2019-09-15T01:06:57Z","timestamp":1568509617000},"page":"112671","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Competitive ELISA method for novel estrogen-negative breast cancer biomarker quantitation"],"prefix":"10.1016","volume":"474","author":[{"given":"Srinidi","family":"Mohan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Lawton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chase","family":"Palmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Augusto Cadenas","family":"Rojas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jim.2019.112671_bb0005","first-page":"334","article-title":"Frequent nitric oxide synthase-2 expression in human colon adenomas: implication for tumor angiogenesis and colon cancer progression","volume":"58","author":"Ambs","year":"1998","journal-title":"Cancer Res."},{"key":"10.1016\/j.jim.2019.112671_bb0010","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1056\/NEJMoa1602253","article-title":"70-Gene signature as an aid to treatment decisions in early-stage breast cancer","volume":"375","author":"Cardoso","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jim.2019.112671_bb0015","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3233\/BD-2010-0307","article-title":"Triple negative breast cancer cell lines: one tool in the search for better treatment of triple negative breast cancer","volume":"32","author":"Chavez","year":"2010","journal-title":"Breast Dis."},{"key":"10.1016\/j.jim.2019.112671_bb0020","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1002\/ijc.21767","article-title":"Tumor iNOS predicts poor survival for stage III melanoma patients","volume":"119","author":"Ekmekcioglu","year":"2006","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jim.2019.112671_bb0025","series-title":"Global Cancer Facts and Figures","author":"Garcia","year":"2007"},{"key":"10.1016\/j.jim.2019.112671_bb0030","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1067\/mlc.2000.105975","article-title":"Decreased plasma concentrations of L-hydroxy-arginine as a marker of reduced NO formation in patients with combined cardiovascular risk factors","volume":"135","author":"Garlichs","year":"2000","journal-title":"J. Lab. Clin. Med."},{"key":"10.1016\/j.jim.2019.112671_bb0035","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1093\/annonc\/mdp492","article-title":"Triple-negative breast cancer--current status and future directions","volume":"20","author":"Gluz","year":"2009","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.jim.2019.112671_bb0040","doi-asserted-by":"crossref","first-page":"3843","DOI":"10.1172\/JCI42059","article-title":"Increased NOS2 predicts poor survival in estrogen receptor-negative breast cancer patients","volume":"120","author":"Glynn","year":"2010","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jim.2019.112671_bb0045","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1016\/0014-2999(95)00046-N","article-title":"Increase in serum NG-hydroxy-L-arginine in rats treated with bacterial lipopolysaccharide","volume":"275","author":"Hecker","year":"1995","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.jim.2019.112671_bb0050","doi-asserted-by":"crossref","first-page":"6323","DOI":"10.1073\/pnas.1401799111","article-title":"Tumor microenvironment-based feed-forward regulation of NOS2 in breast cancer progression","volume":"111","author":"Heinecke","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jim.2019.112671_bb0055","first-page":"1864","article-title":"Breast cancer molecular subtypes: from TNBC to QNBC","volume":"6","author":"Hon","year":"2016","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.jim.2019.112671_bb0060","doi-asserted-by":"crossref","first-page":"12770","DOI":"10.1073\/pnas.220416097","article-title":"Increased p53 mutation load in nontumorous human liver of Wilson disease and hemochromatosis: oxyradical overload diseases","volume":"97","author":"Hussain","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jim.2019.112671_bb0065","doi-asserted-by":"crossref","first-page":"14781","DOI":"10.1016\/S0021-9258(18)82401-2","article-title":"Multiple catalytic functions of brain nitric oxide synthase. Biochemical characterization, cofactor-requirement, and the role of N omega-hydroxy-L-arginine as an intermediate","volume":"268","author":"Klatt","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jim.2019.112671_bb0070","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1007\/s00726-016-2301-5","article-title":"N w-hydroxy-L-arginine as a novel ethnic specific indicator of estrogen-negative breast cancer","volume":"11","author":"Mohan","year":"2016","journal-title":"Amino Acids"},{"key":"10.1016\/j.jim.2019.112671_bb0075","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s00726-017-2523-1","article-title":"Assessing N (w)-hydroxy-L-arginine applicability as a novel ethnic specific estrogen-negative breast cancer marker","volume":"50","author":"Mohan","year":"2017","journal-title":"Amino Acids"},{"key":"10.1016\/j.jim.2019.112671_bb0080","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1007\/s00726-018-2603-x","article-title":"Metabolic relevance for N-hydroxy L-arginine reduction in estrogen-negative breast cancer cells","volume":"50","author":"Mohan","year":"2018","journal-title":"Amino Acids"},{"key":"10.1016\/j.jim.2019.112671_bb0085","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1007\/s00726-015-2019-9","article-title":"Three-minute method for amino acid analysis by UHPLC and high-resolution quadrupole orbitrap mass spectrometry","volume":"47","author":"Nemkov","year":"2015","journal-title":"Amino Acids"},{"key":"10.1016\/j.jim.2019.112671_bb0090","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.niox.2008.04.016","article-title":"Nitric oxide, N omega-hydroxy-L-arginine and breast cancer","volume":"19","author":"Pervin","year":"2008","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.jim.2019.112671_bb0095","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1200\/JCO.2007.15.5986","article-title":"Prognostic significance of Nottingham histologic grade in invasive breast carcinoma","volume":"26","author":"Rakha","year":"2008","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.jim.2019.112671_bb0100","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1158\/1078-0432.CCR-12-0408","article-title":"Molecular pathways: toll-like receptors in the tumor microenvironment--poor prognosis or new therapeutic opportunity","volume":"19","author":"Ridnour","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jim.2019.112671_bb0105","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s00109-013-1021-5","article-title":"The metastasis-promoting roles of tumor-associated immune cells","volume":"91","author":"Smith","year":"2013","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.jim.2019.112671_bb0110","doi-asserted-by":"crossref","first-page":"10869","DOI":"10.1073\/pnas.191367098","article-title":"Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications","volume":"98","author":"Sorlie","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jim.2019.112671_bb0115","doi-asserted-by":"crossref","first-page":"6259","DOI":"10.1016\/S0021-9258(18)38112-2","article-title":"N omega-hydroxy-L-arginine is an intermediate in the biosynthesis of nitric oxide from L-arginine","volume":"266","author":"Stuehr","year":"1991","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jim.2019.112671_bb0120","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/bjc.1995.274","article-title":"Nitric oxide synthase activity in human breast cancer","volume":"72","author":"Thomsen","year":"1995","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jim.2019.112671_bb0125","first-page":"2408","article-title":"Inducible nitric oxide synthase expression, apoptosis, and angiogenesis in in situ and invasive breast carcinomas","volume":"6","author":"Vakkala","year":"2000","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jim.2019.112671_bb0130","doi-asserted-by":"crossref","first-page":"4660","DOI":"10.3748\/wjg.v12.i29.4660","article-title":"Expression of NOS and HIF-1alpha in human colorectal carcinoma and implication in tumor angiogenesis","volume":"12","author":"Yu","year":"2006","journal-title":"World J. Gastroenterol."}],"container-title":["Journal of Immunological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002217591930211X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002217591930211X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T16:38:50Z","timestamp":1758299930000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002217591930211X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":26,"alternative-id":["S002217591930211X"],"URL":"https:\/\/doi.org\/10.1016\/j.jim.2019.112671","relation":{},"ISSN":["0022-1759"],"issn-type":[{"value":"0022-1759","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Competitive ELISA method for novel estrogen-negative breast cancer biomarker quantitation","name":"articletitle","label":"Article Title"},{"value":"Journal of Immunological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jim.2019.112671","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"112671"}}